Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

aspartyl-phenylalanine

Known as: Asp-Phe, N-L-alpha-aspartyl-L-phenylalanine, aspartylphenylalanine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Objective To assess whether prediagnostic metabolites were associated with incident pancreatic ductal adenocarcinoma (PDAC) in a… Expand
2020
2020
Phenylketonuria and tyrosinemia type 1 are treated with dietary phenylalanine (Phe) restriction. Aspartame is a Phe-containing… Expand
2016
2016
Angiotensin-I-converting enzyme (ACE) inhibitors are an important class of antihypertensives whose action on the human organism… Expand
  • figure 1
  • table 2
  • figure 2
2015
2015
A greater understanding of cholestatic disease is necessary to advance diagnostic tools and therapeutic options for conditions… Expand
2014
2014
The mechanism of antihypertensive and lipid-lowering drugs on the human organism is still not fully understood. New insights on… Expand
  • figure 1
2000
2000
Electrospray mass spectrometry was used to simultaneously determine aspartame (APM) and five of its degradation products… Expand
Highly Cited
1997
Highly Cited
1997
Some solid-state pharmaceutical properties and the solid-state thermal stability of the model dipeptides aspartame (APM) and… Expand
1986
1986
Aspartame [Nutrasweet, Equal (Searle Consumer Products, Chicago, Ill.)] is the methyl ester of the dipeptide… Expand
Highly Cited
1976
Highly Cited
1976
Aspartame [SC-18862; 3-amino-N-(alpha-carboxyphenethyl) succinamic acid, methyl ester, the methyl ester of aspartylphenylalanine… Expand
1975
1975
Abstract The methyl ester of aspartylphenylalanine (aspartame; SC-18862; 3-amino- N -(α-carboxyphenethyl)-succinamic acid, methyl… Expand